Facility Evaluation Report

On 05/13/25, Licensing Program Analyst (LPA) Talwinder Bains arrived at the above to conduct a Case Management visit regarding an incident that occurred on 04/16/25 and 04/17/25 for residents R1 and R2 regarding medication error. LPA met with Staff, Lead DSP Jacob Philipsand explained reason for visit.

Incident for R1- Alta California Regional Center Special Incident Report submitted by facility on 04/18/25 to CCL stated that on 04/16/25, at approximately 8PM, while auditing medications, staff discovered that resident, R1 did not get their 5PM dose of Hydroxyzine 50 mg which was 3 times daily as ordered by R1s physician.

Incident for R2- Alta California Regional Center Special Incident Report submitted by facility on 04/18/25 to CCL stated that on 04/17/25, at approximately 8PM, staff was conducting a medication audit when it was noticed that resident, R2 did not receive their 5PM medications as ordered by R2s physician. The missed medications were Clobazmn, half of a I0 mg tablet taken twice a day; Lacosamide, 150 mg tablet taken twice a day; and Oxcarbazepine, 10 mg tablet taken by mouth twice a day.

Facility notified R1s and R2s physician, CCL, ALTA and other agencies regarding these Medication Error.

Based on above information, it was determined that facility did not administer medications for R1 and R2 as ordered by their physician, therefore deficiencies are cited pursuant to California Code of Regulations, Title 22, Section 80075(b)(5)(B) and documented on the attached LIC809D.

The report was reviewed, appeal rights ,LIC809G and a copy of this report was left at the facility.